# Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

> **NCT03814759** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 102 (actual)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **DRUG:** TS-1 + cisplatin
- **RADIATION:** radiation

## Key facts

- **NCT ID:** NCT03814759
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03814759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03814759, "Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03814759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*